Corrigendum to "RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7" [Biochem. Pharmacol. 180 (2020) 114118].

TitleCorrigendum to "RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7" [Biochem. Pharmacol. 180 (2020) 114118].
Publication TypeJournal Article
Year of Publication2020
AuthorsLiang H, Wang Q, Wang D, Zheng H, Kalvakolanu DV, Lu H, Wen N, Chen X, Xu L, Ren J, Guo B, Zhang L
JournalBiochem Pharmacol
Volume182
Pagination114223
Date Published2020 Dec
ISSN1873-2968
DOI10.1016/j.bcp.2020.114223
Alternate JournalBiochem Pharmacol
PubMed ID33039815
Related Faculty: 
Hongwu Zheng, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700